|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.00 USD | +0.33% |
|
+3.82% | +37.31% |
| 07-07 | Protagonist Therapeutics, Inc. - Special Call | |
| 06-17 | Citigroup Initiates Protagonist Therapeutics at Buy With $72 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 56.37 | 59.76 | 56.37 |
| Spread/Res. | -5.98% | -11.31% | -5.98% |
| Spread/Supp. | +11.65% | +51.04% | +16.46% |
| Support | 47.47 | 35.09 | 45.51 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- PTGX Stock
- Charts Protagonist Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition